Matsuo K - Search Results

1

Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?

Vetter MH, Smrz S, Gehrig PA, Peng K, Matsuo K, Davidson BA, Cisa MP, Lees BF, Brunette LL, Tucker K, Stuart Staley A, Gotlieb WH, Holloway RW, Essel KG, Holman LL, Goldfeld E, Olawaiye A, Rose S, Uppal S, Bixel K. Vetter MH, et al. Among authors: matsuo k. Gynecol Oncol. 2020 Nov;159(2):354-358. doi: 10.1016/j.ygyno.2020.08.004. Epub 2020 Sep 2. Gynecol Oncol. 2020. PMID: 32888724

2

Clinical relevance of extent of extreme drug resistance in epithelial ovarian carcinoma.

Matsuo K, Eno ML, Im DD, Rosenshein NB, Sood AK. Matsuo K, et al. Gynecol Oncol. 2010 Jan;116(1):61-5. doi: 10.1016/j.ygyno.2009.09.018. Epub 2009 Oct 17. Gynecol Oncol. 2010. PMID: 19840886 Free PMC article.

3

Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer.

Mabuchi S, Okazawa M, Isohashi F, Matsuo K, Ohta Y, Suzuki O, Yoshioka Y, Enomoto T, Kamiura S, Kimura T. Mabuchi S, et al. Among authors: matsuo k. Gynecol Oncol. 2011 Nov;123(2):241-7. doi: 10.1016/j.ygyno.2011.07.009. Epub 2011 Aug 6. Gynecol Oncol. 2011. PMID: 21820708

4

Inferior vena cava filter placement and risk of hematogenous distant metastasis in ovarian cancer.

Matsuo K, Carter CM, Ahn EH, Prather CP, Eno ML, Im DD, Rosenshein NB. Matsuo K, et al. Am J Clin Oncol. 2013 Aug;36(4):362-7. doi: 10.1097/COC.0b013e318248da32. Am J Clin Oncol. 2013. PMID: 22643565

5

Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.

Mabuchi S, Okazawa M, Matsuo K, Kawano M, Suzuki O, Miyatake T, Enomoto T, Kamiura S, Ogawa K, Kimura T. Mabuchi S, et al. Among authors: matsuo k. Gynecol Oncol. 2012 Oct;127(1):114-20. doi: 10.1016/j.ygyno.2012.06.021. Epub 2012 Jun 21. Gynecol Oncol. 2012. PMID: 22728518

6

The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival.

Matsuo K, Gray MJ, Yang DY, Srivastava SA, Tripathi PB, Sonoda LA, Yoo EJ, Dubeau L, Lee AS, Lin YG. Matsuo K, et al. Gynecol Oncol. 2013 Mar;128(3):552-9. doi: 10.1016/j.ygyno.2012.11.024. Epub 2012 Nov 28. Gynecol Oncol. 2013. PMID: 23200913 Free PMC article.

7

Predictive model of venous thromboembolism in endometrial cancer.

Matsuo K, Yessaian AA, Lin YG, Pham HQ, Muderspach LI, Liebman HA, Morrow CP, Roman LD. Matsuo K, et al. Gynecol Oncol. 2013 Mar;128(3):544-51. doi: 10.1016/j.ygyno.2012.12.014. Epub 2012 Dec 19. Gynecol Oncol. 2013. PMID: 23262205

8

Significance of lymphovascular space invasion in epithelial ovarian cancer.

Matsuo K, Sheridan TB, Yoshino K, Miyake T, Hew KE, Im DD, Rosenshein NB, Mabuchi S, Enomoto T, Kimura T, Sood AK, Roman LD. Matsuo K, et al. Cancer Med. 2012 Oct;1(2):156-64. doi: 10.1002/cam4.31. Epub 2012 Sep 14. Cancer Med. 2012. PMID: 23342265 Free PMC article.

9

Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer.

Matsuo K, Mabuchi S, Okazawa M, Matsumoto Y, Tsutsui T, Fujita M, Kamiura S, Ogawa K, Morrow CP, Kimura T. Matsuo K, et al. Br J Cancer. 2013 Apr 2;108(6):1348-57. doi: 10.1038/bjc.2013.78. Epub 2013 Mar 5. Br J Cancer. 2013. PMID: 23462721 Free PMC article.

10

Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.

Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD. Tierney KE, et al. Among authors: matsuo k. Am J Obstet Gynecol. 2014 Apr;210(4):366.e1-366.e5. doi: 10.1016/j.ajog.2013.12.030. Epub 2013 Dec 24. Am J Obstet Gynecol. 2014. PMID: 24370689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,689 results

Search Page